Purpose of the Screen
- Early detection of open neural tube defects (ONTD).
- Assessing the risk of spina bifida and anencephaly.
- Identifying pregnancies that require follow-up detailed ultrasounds.
Book MSAFP Prenatal Screen in Saudi Arabia | Lahalak Medical Platform
A vital prenatal screening that detects early signs of open neural tube defects and potential spinal abnormalities, providing peace of mind and ensuring proactive medical care for your baby's health.
Scientific name: Maternal Serum Alpha-fetoprotein (MSAFP) Screen
A simple blood test for pregnant women to measure alpha-fetoprotein levels. It assesses the risk of fetal neural tube defects like spina bifida, typically performed between the 15th and 20th weeks of pregnancy.
Service type
Laboratory test
Duration
10-15 minutes
Fasting
Fasting is not required
Included Services
- Venous blood sample collection
- MSAFP level analysis
- Risk assessment report
Medical Service Information
Optimal Timing
- Performed during the second trimester.
- The ideal window is between 16 and 18 weeks of gestation.
- Technically feasible from week 15 through week 20.
Understanding Results
- High levels may suggest neural tube defects or multiple pregnancies.
- Low levels may sometimes be associated with chromosomal abnormalities.
- This is a screening test, not a definitive diagnostic tool.
Conditions & Notices
- Best performed between weeks 15 and 20 of pregnancy
- Accurate gestational age must be provided to the lab
Medical services you might also like
